Related Experiment Video
Updated: Mar 31, 2026

Anti-virulent Disruption of Pathogenic Biofilms using Engineered Quorum-quenching Lactonases
Published on: January 1, 2016
Efficient Inactivation of Multi-Antibiotics Resistant Nosocomial Enterococci by Purified Hiracin Bacteriocin
Maryam Hassan1, Dag Anders Brede2, Dzung B Diep2
1Pharmaceutical Biotechnology Research Center, Zanjan University of Medical Sciences, Zanjan, Iran.
Purpose:
Because of the emergence of multi-antibiotic resistant bacteria, a number of infectious diseases have become a major concern to treat in health care services worldwide. This situation is worsened by the fact that very limited progress has been made in developing new and potent antibiotics in recent years. In this context antimicrobial peptides (AMPs) represent new potential therapeutic compounds with bactericidal or bacteriostatic activity against closely related bacterial strains.
Methods:
In this study, a collection of enterococci (n=170) from clinical sources were investigated for their potential to inhibit multiresistant nosocomial enterococci from Iranian hospitals.
Results:
Four isolates produced antimicrobial peptides that inhibited all the antibiotic resistant enterococci. This included three Enterococcus faecium isolates producing combinations of enterocin A, B and L50 AB. The most potent antagonism was produced by E. faecalis HO91. Purification and subsequent characterization by MALDI-TOF MS, Edman degradation and DNA-sequencing revealed that the antimicrobial compound was Hiracin. The purified Hiracin was evaluated for antibacterial activity against 12 multiresistant enterococcal isolates from clinical samples. The results demonstrated that Hiracin is highly effective towards enterococci which were resistant even to antibiotics from four distinct classes.
Conclusion:
The present research addresses Hiracin as a promising alternative to conventional antibiotics in treatment of multiresistant enterococcal infections.
Insights
Antimicrobial peptides (AMPs) show promise against multi-antibiotic resistant bacteria. A novel compound, Hiracin, derived from Enterococcus faecalis HO91, effectively inhibited resistant enterococci, offering a potential alternative to conventional antibiotics.
Area of Science:
- Microbiology
- Biochemistry
- Infectious Diseases
Background:
- The rise of multi-antibiotic resistant bacteria poses a global health threat.
- Limited development of new antibiotics necessitates alternative therapeutic strategies.
- Antimicrobial peptides (AMPs) are emerging as potential treatments for bacterial infections.
Purpose of the Study:
- To investigate enterococci from clinical sources for their ability to inhibit multiresistant nosocomial enterococci.
- To identify and characterize novel antimicrobial compounds produced by these enterococci.
Main Methods:
- Screening of 170 clinical enterococcal isolates for inhibitory activity.
- Purification and characterization of active compounds using MALDI-TOF MS, Edman degradation, and DNA sequencing.
- Evaluation of the purified compound's antibacterial activity against multiresistant enterococci.
Main Results:
- Four enterococcal isolates produced antimicrobial peptides effective against antibiotic-resistant strains.
- Enterococcus faecalis HO91 produced a potent antimicrobial compound identified as Hiracin.
- Hiracin demonstrated high efficacy against enterococci resistant to multiple antibiotic classes.
Conclusions:
- Hiracin is a promising candidate for treating infections caused by multi-antibiotic resistant enterococci.
- This research highlights AMPs as a viable alternative to conventional antibiotics.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Hand hygiene
Hand washing...
Gene Regulation in Microbial Communities: Quorum Sensing
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Mechanism of Antibiotic Resistance in MRSA
Inhibitors of Bacterial Protein Synthesis

